Management of Raynaud's Phenomenon
All patients with Raynaud's phenomenon should begin with non-pharmacological interventions, and calcium channel blockers (specifically nifedipine) are first-line pharmacological therapy when lifestyle modifications are insufficient. 1, 2
Non-Pharmacological Management (Essential for All Patients)
Trigger avoidance and protective measures form the foundation of management:
- Avoid cold exposure by wearing proper warm clothing including coat, mittens (not gloves), hat, dry insulated footwear, and hand/foot warmers 1
- Smoking cessation is mandatory as tobacco directly worsens vasospasm 1
- Avoid trauma, stress, vibration injury, and vasoconstrictive drugs (bleomycin, clonidine, ergot alkaloids, beta-blockers) 1, 2
- Patient education and self-management support should be offered to improve outcomes and quality of life 1
- Physical exercise should be considered to improve hand function and overall physical capacity 1, 3
Pharmacological Management Algorithm
First-Line: Calcium Channel Blockers
Dihydropyridine-type calcium channel blockers, particularly nifedipine, are first-line therapy due to clinical benefit, low cost, and acceptable adverse effects 1, 2
- Nifedipine reduces both frequency and severity of attacks in meta-analyses of randomized controlled trials 2
- Extended-release formulations (30 mg at bedtime) are preferred 4
- Other dihydropyridine calcium channel blockers can be substituted if nifedipine is poorly tolerated 2
- Common pitfall: 20-50% develop intolerable side effects including hypotension, peripheral edema, and headaches 5, 4
Second-Line: Phosphodiesterase-5 Inhibitors
When calcium channel blockers provide inadequate response or are not tolerated, add or switch to PDE5 inhibitors (sildenafil or tadalafil) 1, 2
- These effectively reduce frequency and severity of Raynaud's attacks 2
- Also effective for both healing and prevention of digital ulcers in secondary Raynaud's 1, 2
- Cost and off-label use may limit utilization 1
Third-Line: Intravenous Prostacyclin Analogues
For severe Raynaud's unresponsive to oral therapies, consider intravenous iloprost 1, 2
- Demonstrated efficacy in reducing frequency and severity of attacks 2
- Most promising drug for secondary Raynaud's disease 6
- Particularly effective for healing existing digital ulcers 1, 2
Management of Digital Ulcers (Secondary Raynaud's)
Digital ulcers require aggressive treatment as they occur in 22.5% of systemic sclerosis patients and can lead to gangrene (11%) or osteomyelitis 1
Prevention of New Digital Ulcers:
- Bosentan (endothelin receptor antagonist) is effective, especially in patients with ≥4 digital ulcers at baseline 1, 2
- PDE5 inhibitors can prevent new ulcers (though evidence is mixed) 1, 2
- Intravenous prostacyclin analogues prevent new ulcers 1
Healing of Existing Digital Ulcers:
- Intravenous iloprost has proven efficacy 1, 2
- PDE5 inhibitors improve healing 1, 2
- Wound care by specialized nurses, antibiotics only when infection suspected, and pain control are essential 1
Ancillary Treatments for Refractory Cases:
- Digital sympathectomy for healing and prevention 1
- Botulinum toxin infiltrations 1
- Fat grafting 1
- Amputation may be required for gangrene or osteomyelitis 1, 2
Primary vs. Secondary Raynaud's: Treatment Differences
Secondary Raynaud's (especially with systemic sclerosis) requires more aggressive pharmacological therapy as it involves not only vasospasm but also fixed blood vessel defects causing more severe ischemia 2, 5
- Primary Raynaud's is often mild enough to manage with lifestyle modifications alone 5
- Secondary Raynaud's typically requires pharmacological intervention and carries higher risk of complications 2, 5
Adjunctive Therapies with Limited Evidence
- Topical nitrates (nitroglycerin) may provide benefit but are limited by headaches and hypotension 1, 5
- Fluoxetine (SSRI) might be considered though evidence is limited 2
- Biofeedback and physical therapy to stimulate blood flow can be beneficial 1, 3
- Avoid relying on alternative treatments (acupuncture, antioxidants, Ginkgo biloba, L-arginine) as systematic reviews show low-quality evidence and inconclusive results 1
Critical Monitoring Points
Regular monitoring is essential in secondary Raynaud's to detect complications early, particularly digital ulcers, gangrene, and osteomyelitis 3